BACE1 and Alzheimer disease: Thus, in the current study, a range of derivatives are synthesized and tested for their ability to treat AD based on their antioxidant and anti-inflammatory effects, BACE-1 inhibitory activity, AChE inhibitory activity, and tau inhibitory activity.